Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

Samankaltaisia teoksia

• Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005
  Tekijä: Dahlen, B., et al.
  Julkaistu: (1997)
• Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects
  Tekijä: Gauvreau, Gail M, et al.
  Julkaistu: (2011)
• Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.
  Tekijä: Freitag, A, et al.
  Julkaistu: (1993)
• Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air
  Tekijä: Fischer, A. R., et al.
  Julkaistu: (1997)
• Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
  Tekijä: Nasser, S. M., et al.
  Julkaistu: (1994)